|
|
||||
|
Meet This Issue's Contributors
The Scientist 2005, 19(15):6
|
||||
|
|
||||
|
As a graduate student in 1996, Benjamin Doranz was involved in some of the initial research on the importance and function of HIV coreceptors. He also learned that as much as he thought he knew about science, research can be far removed from biomedical treatments and solutions. He co-founded Integral Molecular Inc., and on page 40, he writes about why the kind of business training he's received is valuable to scientists both in and out of the lab.
|
|
|||||||||
|
|||||||||
|